HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

GNTA — Genenta Science S.p.A.

GNTA (Genenta Science S.p.A.) stock: $0.68, $32.8M market cap, $33.0M cash, -$0.2M EV, $17.2M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

We are embarking on a strategic transformation to evolve into a next-generation strategic industrial consolidator focused on acquiring privately held businesses operating in national-security regulated sectors contemplated by the “Golden Power” legislation; however, we are currently a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors.

Source: 20-F FY2025 via SEC EDGAR

Share price
$0.68
Market cap
$32.8M
Cash
$33.0M
Enterprise value
-$0.2M

Balance sheet

Cash$33.0M
Debt$0.0M
Net cash$33.0M
Enterprise value-$0.2M
Basic shares23.4M shares
Fully diluted shares25.3M shares
Fully diluted market cap$17.2M
Cash per share$1.41

Cash figures as of 2025-12-31. Database snapshot: 2026-11-07.

Share structure

Common
23.4M
Pre-funded warrants
0.0M
Options
1.9M
RSUs
0.0M
Warrants
0.0M
Converts
—
Conv preferred
0.0M
ESPP reserve
0.0M
FDSO
25.3M

Cap table as of 2025-12-31.

Price history

Loading GNTA daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego